Literature DB >> 17454207

Polycystic ovary syndrome and the single nucleotide polymorphisms of methylenetetrahydrofolate reductase: a pilot observational study.

M Palep-Singh1, H M Picton, Z R Yates, J Barth, A H Balen.   

Abstract

UNLABELLED: Polycystic ovary syndrome (PCOS), insulin resistance and overall mortality due to diabetes and coronary artery disease are higher in South Asians than in Caucasians. AIMS: We compared the prevalence of the C677T and A1298C single nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene in South Asian and Caucasian women, its association with folate and homocysteine (Hcy) metabolism, and its relevance to future atherogenic events. METHODS AND
RESULTS: 71 women were recruited for the study: South Asian PCOS (21) plus controls (9) and Caucasian PCOS (25) plus controls (16). Anthropometric and laboratory parameters were compared. South Asian PCOS women were significantly hyperandrogenic and exhibited a greater degree of insulin resistance. Caucasian PCOS women had higher plasma Hcy concentrations with a 1.9 times higher frequency of the T allele than the South Asian PCOS group. In the presence of this variant allele, plasma Hcy levels appear to be higher in both PCOS groups. The South Asians had a 1.8 times higher frequency of the C allele than the Caucasians; however, the overall frequency was comparable in the two PCOS groups. The frequency of homozygosity, i.e. TT677 and CC1298, was 7.2% and 4.9% in the Caucasians and 0% and 16.6% in the South Asian recruits, respectively. Dietary inadequacies in the South Asian women can influence their plasma folate and B12 concentrations resulting in hyperhomocysteinemia which, in combination with dyslipidaemia and insulin resistance, can lead to long-term atherogenic consequences.
CONCLUSIONS: Current data suggests that the mechanisms of atherothrombosis have separate pathways in the two ethnic groups. Larger studies exploring the current theme need to be carried out in the PCOS groups to obtain adequate insight.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17454207     DOI: 10.1080/14647270600950157

Source DB:  PubMed          Journal:  Hum Fertil (Camb)        ISSN: 1464-7273            Impact factor:   2.767


  10 in total

1.  Methylenetetrahydrofolate reductase C677T gene polymorphism in Turkish patients with polycystic ovary syndrome.

Authors:  Muammer Karadeniz; Mehmet Erdogan; Ayhan Zengi; Zuhal Eroglu; Sadik Tamsel; Murat Olukman; Fusun Saygili; Candeger Yilmaz
Journal:  Endocrine       Date:  2010-07-09       Impact factor: 3.633

2.  A meta-analysis on the association between PPAR-γ Pro12Ala polymorphism and polycystic ovary syndrome.

Authors:  Junli He; Li Wang; Junhong Liu; Feng Liu; Xuliang Li
Journal:  J Assist Reprod Genet       Date:  2012-04-21       Impact factor: 3.412

3.  Is MTHFR 677 C>T Polymorphism Clinically Important in Polycystic Ovarian Syndrome (PCOS)? A Case-Control Study, Meta-Analysis and Trial Sequential Analysis.

Authors:  S Justin Carlus; Saumya Sarkar; Sandeep Kumar Bansal; Vertika Singh; Kiran Singh; Rajesh Kumar Jha; Nirmala Sadasivam; Sri Revathy Sadasivam; P S Gireesha; Kumarasamy Thangaraj; Singh Rajender
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

4.  Association of the Pro12Ala Polymorphism with the Metabolic Parameters in Women with Polycystic Ovary Syndrome.

Authors:  Moushira Zaki; Naglaa Hassan; Hala T El-Bassyouni; Sanaa Kamal; Walaa Basha; Osama Azmy; Khalda Amr
Journal:  Open Access Maced J Med Sci       Date:  2017-06-13

5.  Prevalence of Methylenetetrahydrofolate Reductase C677T Polymorphism in women with Polycystic Ovary Syndrome in southeast of Iran.

Authors:  A Naghavi; H Mozdarani; M Garshasbi; M Yaghmaei
Journal:  J Med Life       Date:  2015

Review 6.  Potential genetic polymorphisms predicting polycystic ovary syndrome.

Authors:  Yao Chen; Shu-Ying Fang
Journal:  Endocr Connect       Date:  2018-04-05       Impact factor: 3.335

7.  Methylenetetrahydrofolate reductase C677T polymorphism and the risks of polycystic ovary syndrome: an updated meta-analysis of 14 studies.

Authors:  Lihong Wang; Wenting Xu; Caihong Wang; Mengyu Tang; Yujia Zhou
Journal:  Oncotarget       Date:  2017-06-14

8.  Methylenetetrahydrofolate reductase gene polymorphisms in the risk of polycystic ovary syndrome and ovarian cancer.

Authors:  Ying Xiong; Ce Bian; Xiaojuan Lin; Xiaoli Wang; Kehui Xu; Xia Zhao
Journal:  Biosci Rep       Date:  2020-07-31       Impact factor: 3.840

9.  Significant association between methylenetetrahydrofolate reductase gene C677T polymorphism with polycystic ovary syndrome risk: A meta-analysis update.

Authors:  Yin Li; Hongqiu Zhu; Min Liu; Zhulan Zeng; Yanling Zeng; Xinlei Xu; Min Ye
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.817

Review 10.  Association between High Serum Homocysteine Levels and Biochemical Characteristics in Women with Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Yuming Meng; Xiang Chen; Zheng Peng; Xuexiang Liu; Yifan Sun; Shengming Dai
Journal:  PLoS One       Date:  2016-06-09       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.